Eagle Health Investments’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-21,802
| Closed | -$7.69M | – | 21 |
|
|
2024
Q4 | $7.69M | Sell |
21,802
-32,297
| -60% | -$11.4M | 1.89% | 14 |
|
|
2024
Q3 | $19.4M | Sell |
54,099
-113,400
| -68% | -$40.6M | 3.67% | 13 |
|
|
2024
Q2 | $53.4M | Sell |
167,499
-12,000
| -7% | -$3.82M | 9.36% | 1 |
|
|
2024
Q1 | $41.2M | Buy |
179,499
+8,661
| +5% | +$1.99M | 7.66% | 4 |
|
|
2023
Q4 | $37.6M | Hold |
170,838
| – | – | 7.63% | 6 |
|
|
2023
Q3 | $38.6M | Hold |
170,838
| – | – | 8.5% | 4 |
|
|
2023
Q2 | $37.7M | Buy |
170,838
+39,600
| +30% | +$8.74M | 7.05% | 4 |
|
|
2023
Q1 | $29.4M | Hold |
131,238
| – | – | 5.72% | 7 |
|
|
2022
Q4 | $36.5M | Sell |
131,238
-9,500
| -7% | -$2.64M | 8.42% | 3 |
|
|
2022
Q3 | $29.5M | Sell |
140,738
-18,500
| -12% | -$3.87M | 6.76% | 4 |
|
|
2022
Q2 | $37.5M | Hold |
159,238
| – | – | 8.75% | 3 |
|
|
2022
Q1 | $28.6M | Buy |
159,238
+5,800
| +4% | +$1.04M | 7.04% | 4 |
|
|
2021
Q4 | $33.2M | Buy |
153,438
+55,400
| +57% | +$12M | 8.08% | 3 |
|
|
2021
Q3 | $18.1M | Hold |
98,038
| – | – | 5.74% | 6 |
|
|
2021
Q2 | $17.6M | Buy |
98,038
+4,938
| +5% | +$886K | 6.03% | 6 |
|
|
2021
Q1 | $15.6M | Buy |
93,100
+23,100
| +33% | +$3.86M | 6.11% | 7 |
|
|
2020
Q4 | $10.6M | Buy |
+70,000
| New | +$10.6M | 6.8% | 7 |
|